# Effect of Varenicline on Cognitive Function in Cigarette Smokers With Schizophrenia

> **NCT01093365** · PHASE2 · COMPLETED · sponsor: **Centre for Addiction and Mental Health** · enrollment: 58 (actual)

## Conditions studied

- Schizophrenia
- Schizoaffective Disorder

## Interventions

- **DRUG:** Varenicline

## Key facts

- **NCT ID:** NCT01093365
- **Lead sponsor:** Centre for Addiction and Mental Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2016-08-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01093365

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01093365, "Effect of Varenicline on Cognitive Function in Cigarette Smokers With Schizophrenia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01093365. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*